layout.fixed.naaccr.doc.naaccr21.rxHospHormone.html Maven / Gradle / Ivy
Go to download
Show more of this group Show more artifacts with this name
Show all versions of layout Show documentation
Show all versions of layout Show documentation
Framework that allows defining file formats (layouts) and use them to read and write data files.
Item #
Length
Source of Standard
Year Implemented
Version Implemented
Year Retired
Version Retired
710
2
CoC
NAACCR XML: Tumor.rxHospHormone
Alternate Names
Hormone Therapy at this Facility (CoC)
Description
Records whether systemic hormonal agents were administered as first-course treatment at this facility or the reason they were not given. Hormone therapy consists of a group of drugs that may affect the long-term control of a cancer’s growth. It is not usually used as a curative measure.
Rationale
Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of hormonal agents given as part of the first course of therapy. Furthermore, it is useful to know the reason hormone therapy was not administered when evaluating quality of care for certain tumors.
If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues.
Codes (Refer to the most recent version of STORE for additional instructions.)
00
None, hormone therapy was not part of the planned first course of therapy. Diagnosed at autopsy.
01
Hormone therapy was administered as first course therapy.
82
Hormone therapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age) or there was progression of disease prior to administration.
85
Hormone therapy was not administered because the patient died prior to planned or recommended therapy.
86
Hormone therapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.
87
Hormone therapy was not administered. It was recommended by the patient's physician, but was refused by the patient, or the patient's family member or guardian. The refusal was noted in the patient record.
88
Hormone therapy was recommended, but it is unknown if it was administered.
99
It is unknown whether hormone therapy was recommended or administered because it is not stated in the patient record; death certificate-only cases.
Note: Codes 02-03 entered under the ROADS rules for tumors diagnosed prior to January 1, 2003, should have been converted to the appropriate code in the new field RX SUMM--Transplnt/Endocr [3250] implemented with
FORDS. Endocrine surgery and endocrine radiation therapy are no longer coded as Hormone Therapy for tumors diagnosed on or after January 1, 2003.